X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (48638) 48638
Book Review (6438) 6438
Newsletter (3942) 3942
Publication (2472) 2472
Book Chapter (365) 365
Conference Proceeding (300) 300
Newspaper Article (114) 114
Dissertation (101) 101
Magazine Article (71) 71
Reference (19) 19
Book / eBook (14) 14
Transcript (13) 13
Web Resource (6) 6
Data Set (4) 4
Streaming Video (3) 3
Trade Publication Article (3) 3
Government Document (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (39036) 39036
animals (23309) 23309
humans (22487) 22487
glucagon (19000) 19000
male (18760) 18760
female (11758) 11758
rats (11435) 11435
endocrinology & metabolism (10037) 10037
insulin (9297) 9297
glucagon-like peptide-1 (8993) 8993
glucose (7805) 7805
adult (7517) 7517
glucagon - pharmacology (7489) 7489
insulin - blood (7424) 7424
glucagon - blood (7186) 7186
insulin - metabolism (6612) 6612
blood glucose - metabolism (6500) 6500
diabetes (6332) 6332
abridged index medicus (6146) 6146
middle aged (5839) 5839
glucagon - metabolism (5325) 5325
mice (5177) 5177
research (5125) 5125
type 2 diabetes (5084) 5084
insulin secretion (4703) 4703
liver - metabolism (4021) 4021
diabetes mellitus, type 2 - drug therapy (3425) 3425
biochemistry & molecular biology (3288) 3288
glucose - metabolism (3241) 3241
blood glucose - analysis (3196) 3196
glucagon-like peptide 1 (3178) 3178
physiological aspects (3136) 3136
obesity (3129) 3129
dextrose (3088) 3088
secretion (3047) 3047
physiology (3039) 3039
aged (2971) 2971
peptides (2948) 2948
time factors (2819) 2819
islets of langerhans - metabolism (2761) 2761
pharmacology & pharmacy (2757) 2757
kinetics (2725) 2725
glp-1 (2652) 2652
metabolism (2628) 2628
analysis (2604) 2604
hypoglycemic agents - therapeutic use (2549) 2549
diabetes mellitus (2519) 2519
insulin - pharmacology (2502) 2502
dogs (2473) 2473
insulin resistance (2374) 2374
pancreas (2292) 2292
glucose tolerance test (2273) 2273
liver - drug effects (2215) 2215
glucose metabolism (2153) 2153
glucose - pharmacology (2134) 2134
rats, inbred strains (2110) 2110
in vitro techniques (2086) 2086
diabetes therapy (2026) 2026
liver (1902) 1902
hyperglycemia (1862) 1862
dose-response relationship, drug (1838) 1838
hormones (1838) 1838
expression (1829) 1829
cells, cultured (1822) 1822
care and treatment (1778) 1778
rodents (1752) 1752
medicine & public health (1732) 1732
internal medicine (1729) 1729
adolescent (1713) 1713
glucagon-like peptide 1 - metabolism (1709) 1709
rats, sprague-dawley (1703) 1703
cell biology (1685) 1685
liraglutide (1680) 1680
diabetes mellitus, type 2 - metabolism (1675) 1675
insulin-secretion (1649) 1649
islets of langerhans - drug effects (1645) 1645
health aspects (1643) 1643
rats, wistar (1633) 1633
glucagon-like peptide-1 receptor (1630) 1630
diabetes mellitus, type 2 - blood (1613) 1613
fasting (1594) 1594
body weight (1579) 1579
hypoglycemia (1579) 1579
fatty acids, nonesterified - blood (1567) 1567
homeostasis (1563) 1563
hypoglycemic agents - pharmacology (1543) 1543
glycemic control (1532) 1532
reports (1520) 1520
nutrition & dietetics (1518) 1518
proteins (1509) 1509
liver - enzymology (1507) 1507
medicine, research & experimental (1498) 1498
blood glucose - drug effects (1459) 1459
food-intake (1453) 1453
cyclic amp - metabolism (1408) 1408
gastroenterology & hepatology (1389) 1389
peptides - pharmacology (1388) 1388
surgery (1381) 1381
glucagon - physiology (1373) 1373
mice, inbred c57bl (1356) 1356
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (48975) 48975
German (890) 890
Japanese (780) 780
French (737) 737
Italian (404) 404
Russian (326) 326
Spanish (271) 271
Polish (188) 188
Chinese (177) 177
Czech (71) 71
Korean (68) 68
Portuguese (48) 48
Hungarian (43) 43
Danish (39) 39
Swedish (34) 34
Dutch (21) 21
Norwegian (19) 19
Turkish (19) 19
Romanian (18) 18
Slovak (16) 16
Bulgarian (15) 15
Finnish (10) 10
Ukrainian (10) 10
Serbian (9) 9
Croatian (6) 6
Hebrew (6) 6
Slovenian (4) 4
Lithuanian (3) 3
Afrikaans (2) 2
Arabic (1) 1
Bosnian (1) 1
Greek (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, ISSN 0012-1797, 11/2011, Volume 60, Issue 11, pp. 2872 - 2882
OBJECTIVE-To evaluate whether healthy or diabetic adult mice can tolerate an extreme loss of pancreatic a-cells and how this sudden massive depletion affects... 
INSULIN | HYPERGLUCAGONEMIA | ENDOCRINE PANCREAS | GLUCOSE-HOMEOSTASIS | ENDOCRINOLOGY & METABOLISM | RECEPTOR GENE | SECRETION | DIFFERENTIATION | HYPERPLASIA | ISLET CELLS | EXPRESSION | Insulin-Secreting Cells - secretion | Apoptosis - drug effects | Cell Count | Glucagon - genetics | Male | Diphtheria Toxin - toxicity | Insulin - blood | Glucagon - blood | Diabetes Mellitus, Experimental - blood | Hypoglycemia - prevention & control | Intercellular Signaling Peptides and Proteins - metabolism | Glucagon-Secreting Cells - drug effects | Insulin-Secreting Cells - metabolism | Hyperglycemia - chemically induced | Glucagon-Secreting Cells - metabolism | Diabetes Mellitus, Experimental - chemically induced | Diabetes Mellitus, Experimental - metabolism | Glucagon-Secreting Cells - secretion | Hyperglycemia - prevention & control | Promoter Regions, Genetic | Signal Transduction | Glucagon-Secreting Cells - pathology | Intercellular Signaling Peptides and Proteins - genetics | Pancreas - drug effects | Pancreas - pathology | Receptors, Glucagon - metabolism | Mice, Transgenic | Pancreas - metabolism | Heparin-binding EGF-like Growth Factor | Insulin - metabolism | Animals | Insulin-Secreting Cells - drug effects | Tamoxifen - pharmacology | Diabetes Mellitus, Experimental - pathology | Glucagon - metabolism | Mice | Streptozocin - toxicity | Insulin-Secreting Cells - pathology | Selective Estrogen Receptor Modulators - pharmacology | Index Medicus | Abridged Index Medicus | Islet Studies
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 02/2019, Volume 21, Issue 2, pp. 446 - 447
Journal Article
by Li, Y and Cai, Z
Clinical Nutrition, ISSN 0261-5614, 09/2017, Volume 36, pp. S202 - S202
Journal Article
Gastroenterology, ISSN 0016-5085, 08/2004, Volume 127, Issue 2, pp. 546 - 558
Background & Aims: Gut-derived peptides including ghrelin, cholecystokinin (CCK), peptide YY (PYY), glucagon-like peptide (GLP-1), and GLP-2 exert overlapping... 
GIP receptor | GLUR | GIPR | OXM | GLP-1 receptor | glucagon receptor | PGDP | cholecystokinin | CCK | GLP | G-protein-coupled receptors | proglucagon-derived peptide | oxyntomodulin | PYY | GPCRs | glucagon-like peptide | Ex-4 | peptide YY | exendin-4 | GLP-1R | NERVOUS-SYSTEM | 1-3 JEJUNOILEAL RATIO | IN-VITRO | BODY-WEIGHT GAIN | OBESE RATS | POLYPEPTIDE RECEPTOR | PIG PANCREAS | GENE-EXPRESSION | PANCREATIC BETA-CELLS | GLP-1 RECEPTOR | GASTROENTEROLOGY & HEPATOLOGY | Glucagon-Like Peptide 1 | Glucagon-Like Peptide 2 | Iodine Radioisotopes | Receptors, G-Protein-Coupled - metabolism | Glucagon - genetics | Injections, Intraventricular | Molecular Sequence Data | Peptide Fragments - pharmacology | Brain - metabolism | Dose-Response Relationship, Drug | Glucagon-Like Peptides - pharmacology | Peptides - metabolism | Proglucagon | Binding, Competitive | Receptors, Glucagon - agonists | Receptors, Glucagon - genetics | Amino Acid Sequence | Cricetinae | Peptide Fragments - metabolism | Protein Precursors - genetics | Mice, Inbred C57BL | Cells, Cultured | Injections, Intraperitoneal | Proto-Oncogene Proteins c-fos - metabolism | Rats | Receptors, Glucagon - metabolism | Oxyntomodulin | Glucagon - pharmacology | Mice, Knockout | Peptides - pharmacology | Protein Precursors - metabolism | Eating - drug effects | Protein Precursors - pharmacology | Glucagon-Like Peptides - metabolism | Animals | Glucagon-Like Peptide-1 Receptor | Glucagon - metabolism | Mice | Receptors, G-Protein-Coupled - genetics | Venoms - pharmacology | Venoms - metabolism | Energy Metabolism - drug effects | Glucagon | Cholecystokinin | Index Medicus | Abridged Index Medicus
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 02/2016, Volume 471, Issue 1, p. 47
Glucagon-like peptide-1 receptor (GLP-1R) is abundantly expressed on beta cells and may be an ideal target for the pancreas imaging. Monitoring the GLP-1R of... 
Glucagon
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 09/2015, Volume 58, Issue 18, pp. 7370 - 7380
Journal Article
Nature, ISSN 0028-0836, 06/2017, Volume 546, Issue 7657, pp. 248 - 253
Journal Article
Clinical Biochemistry, ISSN 0009-9120, 08/2016, Volume 49, Issue 12, p. 897
Glucagon-like peptide-1 (GLP-1) is a peptide hormone secreted by intestinal L-cells which stimulates glucose-dependent insulin secretion. GLP-1 is initially... 
Glucagon
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 01/2015, Volume 93, Issue 1, p. 72
Journal Article
Nuclear Medicine and Biology, ISSN 0969-8051, 12/2015, Volume 42, Issue 12, p. 911
About 90% of insulinomas are benign and 5%-15% are malignant. Benign insulinomas express the glucagon-like peptide-1 receptor (GLP-1R) and low levels of... 
Glucagon
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, p. e91525
Journal Article
Nutrition clinique et metabolisme, ISSN 0985-0562, 03/2019, Volume 33, Issue 1, p. 21
Discipline La chirurgie bariatrique connait un essor considerable dans le traitement de l'obesite. Les deux interventions de reference sont la Sleeve... 
Glucagon
Journal Article
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 04/2012, Volume 32, Issue 14, pp. 4812 - 4820
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e66214
Journal Article
Journal Article
Diabetologia, ISSN 0012-186X, 11/2011, Volume 54, Issue 11, pp. 2745 - 2754
The innate immune cells, invariant natural killer T cells (iNKT cells), are implicated in the pathogenesis of psoriasis, an inflammatory condition associated... 
Invariant NKT cells | Obesity | Human Physiology | Psoriasis | GLP-1 receptor | Metabolic Diseases | Internal Medicine | Innate immune system | CREB | Medicine & Public Health | GLP-1 analogue | Diabetes | Anti-inflammatory | SYSTEM | NKT CELLS | METABOLIC SYNDROME | NOD MICE | MYOCARDIAL-INFARCTION | RISK | THERAPY | INFLAMMATION | ENDOCRINOLOGY & METABOLISM | BARIATRIC SURGERY | ONSET | Natural Killer T-Cells - drug effects | Cell Count | Humans | Middle Aged | Male | Diabetes Mellitus, Type 2 - metabolism | Molecular Targeted Therapy | RNA, Messenger - metabolism | Psoriasis - complications | Glucagon-Like Peptide 1 - agonists | Natural Killer T-Cells - metabolism | Diabetes Mellitus, Type 2 - immunology | Psoriasis - metabolism | Female | Diabetes Mellitus, Type 2 - complications | Skin - pathology | Natural Killer T-Cells - secretion | Skin - immunology | Hypoglycemic Agents - therapeutic use | Psoriasis - immunology | Receptors, Glucagon - agonists | Receptors, Glucagon - genetics | Severity of Illness Index | Cell Line | Psoriasis - drug therapy | Glucagon-Like Peptide 1 - metabolism | Glucagon-Like Peptide 1 - analogs & derivatives | Obesity - complications | Cytokines - secretion | Glucagon-Like Peptide 1 - pharmacology | Receptors, Glucagon - metabolism | Hypoglycemic Agents - pharmacology | Gene Expression Regulation - drug effects | Glucagon-Like Peptide-1 Receptor | Signal Transduction - drug effects | Immunologic Factors - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Immunologic Factors - pharmacology | Liraglutide | Skin - drug effects | Glucagon-Like Peptide 1 - therapeutic use | Immunologic Factors - therapeutic use | Natural Killer T-Cells - immunology | Type 2 diabetes | Peptides | T cells | Emergency medical services | Index Medicus
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 02/2018, Volume 20, Issue 2, pp. 468 - 473
A retrospective cohort study was conducted in patients with type 2 diabetes in an electronic medical record database to compare real‐world, 6‐month glycated... 
GLP | glycaemic control | type 2 diabetes | dulaglutide | database research | exenatide | GLP-1 | METFORMIN | RETROSPECTIVE COHORT | OPEN-LABEL | RANDOMIZED CONTROLLED-TRIAL | ALBIGLUTIDE | WEEKLY DULAGLUTIDE | NON-INFERIORITY | DAILY LIRAGLUTIDE | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Glycated Hemoglobin A - analysis | Follow-Up Studies | Glucagon-Like Peptide 1 - administration & dosage | Recombinant Fusion Proteins - adverse effects | Glucagon-Like Peptides - administration & dosage | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Weight Loss - drug effects | Immunoglobulin Fc Fragments - administration & dosage | Hypoglycemia - prevention & control | Glucagon-Like Peptide-1 Receptor - metabolism | Hypoglycemic Agents - administration & dosage | Adult | Female | Immunoglobulin Fc Fragments - therapeutic use | Retrospective Studies | Glucagon-Like Peptides - analogs & derivatives | Diabetes Mellitus, Type 2 - complications | Immunoglobulin Fc Fragments - adverse effects | Recombinant Fusion Proteins - administration & dosage | Exenatide - adverse effects | Body Mass Index | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Exenatide - therapeutic use | Drug Administration Schedule | Glucagon-Like Peptide 1 - analogs & derivatives | Obesity - complications | Glucagon-Like Peptides - adverse effects | Diabetes Mellitus, Type 2 - blood | Exenatide - administration & dosage | Aged | Glucagon-Like Peptides - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Glucagon-Like Peptide-1 Receptor - agonists | Cohort Studies | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Medical research | Care and treatment | Glucagon | Patient outcomes | Glycosylated hemoglobin